2017
DOI: 10.1016/j.anpedi.2016.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Pacientes españoles con síndrome de hipoventilación central incluidos en el Registro europeo. Datos del 2015

Abstract: The implementation of the EuCHS Registry in Spain has identified some relevant issues for optimising healthcare, such as the importance of genetic study for diagnosis and assessment of severity, the high frequency of eye disease and educational reinforcement, as well as some limitations in ventilatory techniques.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 39 publications
0
3
0
Order By: Relevance
“…There were six studies (6/60, 10%) on NIV use for infants with central hypoventilation syndrome (CHS) that reported primary or secondary outcomes, and all six were summarized (Table 2 ) ( 60 65 ). The diagnosis of CHS was confirmed clinically in two studies ( 61 , 65 ), via PHOX2B gene mutation analysis in three studies ( 60 , 62 , 64 ), and unreported in one study ( 63 ). NIV was used in conjunction with negative extra-thoracic pressure ventilation (VNEP) therapy in two studies: in one study, it was used as the primary therapy ( 65 ) and, in the second study, CPAP was used to relieve upper airway obstruction not resolved with VNEP ( 61 ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…There were six studies (6/60, 10%) on NIV use for infants with central hypoventilation syndrome (CHS) that reported primary or secondary outcomes, and all six were summarized (Table 2 ) ( 60 65 ). The diagnosis of CHS was confirmed clinically in two studies ( 61 , 65 ), via PHOX2B gene mutation analysis in three studies ( 60 , 62 , 64 ), and unreported in one study ( 63 ). NIV was used in conjunction with negative extra-thoracic pressure ventilation (VNEP) therapy in two studies: in one study, it was used as the primary therapy ( 65 ) and, in the second study, CPAP was used to relieve upper airway obstruction not resolved with VNEP ( 61 ).…”
Section: Resultsmentioning
confidence: 99%
“…One study with six infants reported NIV discontinuation in two infants (33%) because of improvements in respiratory parameters; the remaining four infants were using NIV only during sleep ( 61 ). One cohort study reported mortality outcomes and a higher hospitalization time for infants using invasive mechanical ventilation compared to NIV (Table 4 ) ( 60 ). Two studies showed parent-reported improvements in growth and development after NIV initiation using the results of a parent questionnaire ( 61 , 63 ).…”
Section: Resultsmentioning
confidence: 99%
“…CCHS (2020-ICD-10-CM and ICSD3 code: G47.35; MIM 209880, ORPHA 661) is a rare condition, the incidence of which has been estimated to be at 1/148,000–1/200,000 live births [ 84 , 92 ], and the prevalence at 1/500,000 individuals [ 92 ]. Clinical hallmarks of CCHS are well-described: central hypoventilation due to abnormally reduced or absent ventilatory responses to hypercapnia and hypoxia and associated manifestations of autonomic dysfunction such as Hirschsprung disease (HD) and neural crest tumours [ 32 , 106 ].…”
Section: Introductionmentioning
confidence: 99%